tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMUX Stock Latest News

Immunic price target lowered to $5 from $6 at B. Riley
The FlyImmunic price target lowered to $5 from $6 at B. Riley
5h ago
IMUX
Buy Rating Affirmed for Immunic’s Vidofludimus Calcium Due to Promising Phase 2 Results and Strong MS Treatment Potential
PremiumRatings
Buy Rating Affirmed for Immunic’s Vidofludimus Calcium Due to Promising Phase 2 Results and Strong MS Treatment Potential
7d ago
IMUX
Immunic’s Promising Clinical Data and Strategic Financial Position Justify Buy Rating
PremiumRatings
Immunic’s Promising Clinical Data and Strategic Financial Position Justify Buy Rating
7d ago
IMUX
Positive Phase 2 Trial Results for VidoCa in PMS Bolster Buy Rating for Immunic
PremiumRatings
Positive Phase 2 Trial Results for VidoCa in PMS Bolster Buy Rating for Immunic
8d ago
IMUX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
21d ago
ATOS
CYCC
Promising Phase 2 Results for Vidofludimus Calcium in Progressive Multiple Sclerosis Highlight Potential for Neuroprotection and Disease Modification
PremiumRatingsPromising Phase 2 Results for Vidofludimus Calcium in Progressive Multiple Sclerosis Highlight Potential for Neuroprotection and Disease Modification
22d ago
IMUX
Immunic price target raised to $22 from $19 at Brookline
Premium
The Fly
Immunic price target raised to $22 from $19 at Brookline
23d ago
IMUX
Immunic’s Vidofludimus Calcium Shows Promise in Treating Progressive MS: Analyst Upgrades to Buy
Premium
Ratings
Immunic’s Vidofludimus Calcium Shows Promise in Treating Progressive MS: Analyst Upgrades to Buy
23d ago
IMUX
Immunic’s vidofludimus calcium shows positive results in Phase 2 PMS trial
PremiumThe Fly
Immunic’s vidofludimus calcium shows positive results in Phase 2 PMS trial
23d ago
IMUX
Immunic’s Vidofludimus Calcium: A Promising MS Treatment with Dual Mechanism and Positive Trial Results Justifying Buy Rating
PremiumRatings
Immunic’s Vidofludimus Calcium: A Promising MS Treatment with Dual Mechanism and Positive Trial Results Justifying Buy Rating
1M ago
IMUX
Immunic Announces $5.1 Million Securities Purchase Agreement
PremiumCompany Announcements
Immunic Announces $5.1 Million Securities Purchase Agreement
1M ago
8K
IMUX
Immunic sells 5.67M shares at 90c in registered direct offering
PremiumThe Fly
Immunic sells 5.67M shares at 90c in registered direct offering
1M ago
IMUX
Immunic, US Steel, KLA, IIPR, Goodyear: Trending by Analysts
PremiumWeekend UpdatesImmunic, US Steel, KLA, IIPR, Goodyear: Trending by Analysts
2M ago
X
GT
Optimistic Buy Rating for Immunic Driven by Promising Multiple Sclerosis Trials and Financial Stability
Premium
Ratings
Optimistic Buy Rating for Immunic Driven by Promising Multiple Sclerosis Trials and Financial Stability
2M ago
IMUX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
PTN
SNY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ALLR
ALNY
Immunic initiated with an Outperform at William Blair
PremiumThe Fly
Immunic initiated with an Outperform at William Blair
2M ago
IMUX
Buy Rating on Immunic Driven by Promising CALLIPER Study Outcomes and Market Opportunities in Progressive Multiple Sclerosis
PremiumRatings
Buy Rating on Immunic Driven by Promising CALLIPER Study Outcomes and Market Opportunities in Progressive Multiple Sclerosis
2M ago
IMUX
Immunic’s Vidofludimus Calcium: A Promising Disruptor in the $45 Billion Multiple Sclerosis Market
PremiumRatings
Immunic’s Vidofludimus Calcium: A Promising Disruptor in the $45 Billion Multiple Sclerosis Market
2M ago
IMUX
Immunic management to meet virtually with Piper Sandler
PremiumThe FlyImmunic management to meet virtually with Piper Sandler
2M ago
IMUX
Immunic announces IMU-856 demonstrated dose-dependent increase
Premium
The Fly
Immunic announces IMU-856 demonstrated dose-dependent increase
3M ago
IMUX
Immunic, Inc. (IMUX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Immunic, Inc. (IMUX) Q4 Earnings Cheat Sheet
3M ago
IMUX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >